Efficacy and Tolerability of ABB I5 Prebiotic and ABB C22 Postbiotics for the Management of Constipation and Gastrointestinal Well-being: a Pilot Trial
Clinical trial NCT06738433 · COMPLETED
Trial details
- NCT number
- NCT06738433
- Sponsor
- AB Biotek
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2024-04-04
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.